Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC
How Have Kids' Colorectal Cancer Rates Changed?
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
Hypertension After Kidney Donation; Statins in Old and Very Old People
Desktop versie